- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT07566273
Micropractices for Unhoused LGBTQ Youth
29. April 2026 aktualisiert von: Cornell University
Developing and Evaluating Collaboratively Designed Mindfulness and Identity-Affirming Practices for Unhoused LGBTQ Youth
In the present study, the investigators will conduct a pilot randomized controlled trial to evaluate the feasibility, acceptability, and preliminary efficacy of brief, co-designed mindfulness and identity-affirming micropractices for LGBTQ youth and young adults experiencing housing instability.
Participants (n = 200, accounting for anticipated attrition) will be randomly assigned to one of two conditions: (1) a mindfulness and identity-based micropractice condition or (2) a structurally equivalent neutral control condition.
The intervention content will be developed using a participatory co-design process with members of the target population and standardized prior to trial implementation.
The mindfulness and identity condition integrates brief practices targeting present-moment awareness and identity affirmation, whereas the control condition accounts for time and attention without including these components.
Assessments will be conducted at baseline, post-intervention, and three-month follow-up.
Primary outcomes include feasibility and acceptability, assessed using standardized implementation outcome measures and indicators of intervention adherence.
Secondary outcomes include changes in mental health symptoms, psychological and emotional well-being, and substance use.
The investigators will evaluate whether the mindfulness and identity-based condition demonstrates greater improvements in outcomes compared to the control condition and will estimate effect sizes to inform the design of future fully powered trials.
The intervention will be delivered via a mobile-accessible platform.
Studienübersicht
Status
Noch keine Rekrutierung
Bedingungen
Intervention / Behandlung
Detaillierte Beschreibung
Specific Aim 1: Evaluate the feasibility and acceptability of delivering co-designed mindfulness and identity-affirming micropractices to LGBTQ youth experiencing housing instability over a 30-day period.
Hypothesis 1: Participants in the mindfulness and identity-based condition will demonstrate higher adherence (e.g., daily completion rates) and report greater acceptability compared to the neutral control condition.
Specific Aim 2: Determine whether the mindfulness and identity-based micropractice condition, relative to the control condition, is associated with improvements in psychological and emotional well-being and reductions in distress and substance use.
Hypothesis 2: Participants in the mindfulness and identity-based condition will show greater increases in well-being and greater reductions in anxiety, depressive symptoms, and substance use from baseline to post-intervention and to three-month follow-up compared to the control condition.
Specific Aim 3: Assess whether engagement with the intervention (e.g., adherence to daily micropractices) is associated with improvements in psychosocial outcomes.
Hypothesis 3: Greater engagement with the mindfulness and identity-based micropractices will be associated with greater improvements in well-being and greater reductions in distress across the study period.
Exploratory Aim: Evaluate participants' experiences with the intervention, including perceived benefits, challenges, and contextual relevance of the micropractices.
This aim will be addressed through qualitative feedback collected during the study period.
The investigators will characterize common themes related to usability, relevance, and barriers to engagement, and will examine whether the intervention meets predefined criteria for feasibility and acceptability.
Studientyp
Interventionell
Einschreibung (Geschätzt)
200
Phase
- Frühphase 1
Kontakte und Standorte
Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.
Studienorte
-
-
New York
-
New York, New York, Vereinigte Staaten, 10018
- Ali Forney Center
-
-
Teilnahmekriterien
Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.
Zulassungskriterien
Studienberechtigtes Alter
- Kind
- Erwachsene
Akzeptiert gesunde Freiwillige
Ja
Beschreibung
Inclusion Criteria:
- Aged 16 to 26 years
- Self-identify as LGBTQ
- Currently or recently experiencing housing instability (within the past six months)
- Have access to a mobile device with internet capability to complete study activities
Exclusion Criteria:
- Unable to complete study procedures (e.g., lack of device access)
Studienplan
Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Verhütung
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Single
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Experimental: Mindfulness and Identity Condition
Participants will be assigned to complete a brief daily micropractice that integrates mindfulness (e.g., attention to breathing or present-moment awareness) with reflection on personally meaningful aspects of identity.
The micropractice is delivered via a mobile-accessible platform over a 30-day period.
|
Participants will complete a brief daily micropractice (approximately 1-5 minutes per day) that integrates mindfulness (e.g., attention to breathing or present-moment awareness) with reflection on personally meaningful aspects of identity.
The micropractice is co-designed with members of the target population, standardized prior to the trial, and delivered via a mobile-accessible platform.
|
|
Aktiver Komparator: Control Condition
Participants will be assigned to complete a brief daily activity matched in structure, duration, and delivery format, but without mindfulness or identity-based content.
Activities focus on neutral reflections (e.g., daily routines or surroundings) and are delivered via a mobile-accessible platform over a 30-day period.
|
Participants will complete a brief daily activity (approximately 1-5 minutes per day) matched in structure and delivery format to the intervention condition, but without mindfulness or identity-based content.
Activities include neutral reflections (e.g., daily routines or surroundings) and are delivered via a mobile-accessible platform.
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Acceptability (Acceptability of Intervention Measure [AIM])
Zeitfenster: Assessed at post-intervention (30 days) and 3-month follow-up.
|
Assessed using four items measuring participant-reported implementation outcome items evaluating approval, liking, and overall acceptance of the assigned activity.
Responses are given on a 5-point Likert scale.
Higher scores indicate greater acceptability.
|
Assessed at post-intervention (30 days) and 3-month follow-up.
|
|
Appropriateness (Intervention Appropriateness Measure [IAM])
Zeitfenster: Assessed at post-intervention (30 days) and 3-month follow-up.
|
Assessed using four items measuring participant-reported implementation outcome items evaluating whether the assigned activity seems relevant, fitting, and compatible with participants' lives.
Responses are given on a 5-point Likert scale.
Higher scores indicate greater appropriateness.
|
Assessed at post-intervention (30 days) and 3-month follow-up.
|
|
Feasibility (Feasibility of Intervention Measure [FIM])
Zeitfenster: Assessed at post-intervention (30 days) and 3-month follow-up.
|
Assessed using four items measuring participant-reported implementation outcome items evaluating whether the assigned activity seems workable, possible, and easy to do in daily life.
Responses are given on a 5-point Likert scale.
Higher scores indicate greater feasibility.
|
Assessed at post-intervention (30 days) and 3-month follow-up.
|
|
Intervention adherence
Zeitfenster: Assessed daily during the 30-day intervention period.
|
Assessed by self-reported completion of the assigned daily activity during the 30-day intervention period.
Higher adherence indicates a better outcome.
|
Assessed daily during the 30-day intervention period.
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Purpose in Life (Life Engagement Test [LET])
Zeitfenster: Change from baseline to post-intervention (30 days), and to 3-month follow-up.
|
Assessed using 6 items measuring the extent to which participants experience purpose, meaning, and value in their daily activities.
Responses are given on a 5-point Likert scale.
Higher scores indicate greater purpose.
|
Change from baseline to post-intervention (30 days), and to 3-month follow-up.
|
|
Depressive Symptoms (Center for Epidemiologic Studies Depression Scale [CES-D])
Zeitfenster: Change from baseline to post-intervention (30 days), and to 3-month follow-up.
|
Assessed using 10 items measuring depressive symptoms during the past week.
Responses are given on a 4-point Likert scale.
Higher scores indicate greater depressive symptoms.
Lower scores indicate a better outcome.
|
Change from baseline to post-intervention (30 days), and to 3-month follow-up.
|
|
Anxiety Symptoms (Generalized Anxiety Disorder-7 Scale [GAD-7])
Zeitfenster: Change from baseline to post-intervention (30 days), and to 3-month follow-up.
|
Assessed using 7 items measuring anxiety symptoms over the last 2 weeks.
Responses are given on a 4-point Likert scale.
Higher scores indicate greater anxiety symptoms.
Lower scores indicate a better outcome.
|
Change from baseline to post-intervention (30 days), and to 3-month follow-up.
|
|
Psychological, emotional, and social well-being (Mental Health Continuum- Short Form [MHC-SF])
Zeitfenster: Change from baseline to post-intervention (30 days), and to 3-month follow-up.
|
Assessed using 14 items measuring emotional, psychological, and social well-being during the past month.
Responses are given on a 6-point Likert scale.
Higher scores indicate greater well-being.
|
Change from baseline to post-intervention (30 days), and to 3-month follow-up.
|
|
Self-Esteem (Rosenberg Self-Esteem Scale [RSE])
Zeitfenster: Change from baseline to post-intervention (30 days), and to 3-month follow-up.
|
Assessed using 10 items measuring global self-esteem over the past 30 days.
Responses are given on a 5-point Likert scale.
Higher scores indicate greater self-esteem.
|
Change from baseline to post-intervention (30 days), and to 3-month follow-up.
|
|
Authenticity (Authenticity Scale)
Zeitfenster: Change from baseline to post-intervention (30 days), and to 3-month follow-up.
|
Includes two dimensions of the Authenticity Scale: Self-Alienation and Authentic Living.
Self-Alienation is assessed using 4 items measuring participants' sense of being out of touch with the "real me".
Higher scores indicate lower authenticity.
Authentic Living is assessed using 4 items measuring participants' sense of being true to themselves, their beliefs, and values.
Higher scores indicate greater authenticity.
Responses are given on a 7-point Likert scale.
|
Change from baseline to post-intervention (30 days), and to 3-month follow-up.
|
|
Substance Use Risk (CRAFFT Screening Test)
Zeitfenster: Change from baseline to post-intervention (30 days), and to 3-month follow-up.
|
Assessed using 11 items measuring likelihood of alcohol- and drug-related risk behaviors over the past 30 days.
Responses are given on a 5-point Likert scale.
Higher scores indicate greater substance use risk.
Lower scores indicate a better outcome.
|
Change from baseline to post-intervention (30 days), and to 3-month follow-up.
|
Andere Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Likelihood of recommending the assigned activity to a friend
Zeitfenster: Assessed at post-intervention (30 days) and 3-month follow-up.
|
Assessed using a single item asking how likely participants are to recommend the assigned activity to a friend, rated from 0 to 10. Higher scores indicate greater willingness to recommend the activity.
|
Assessed at post-intervention (30 days) and 3-month follow-up.
|
|
Participant feedback on barriers and overall experience
Zeitfenster: Assessed during the 30-day intervention period.
|
Assessed using open-ended items asking participants about reasons for not completing daily activities, comments about the study, and perceived benefits or challenges related to participation.
Responses will be analyzed qualitatively.
|
Assessed during the 30-day intervention period.
|
Mitarbeiter und Ermittler
Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.
Sponsor
Mitarbeiter
Studienaufzeichnungsdaten
Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.
Haupttermine studieren
Studienbeginn (Geschätzt)
1. Oktober 2026
Primärer Abschluss (Geschätzt)
1. November 2026
Studienabschluss (Geschätzt)
1. Januar 2027
Studienanmeldedaten
Zuerst eingereicht
29. April 2026
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
29. April 2026
Zuerst gepostet (Tatsächlich)
5. Mai 2026
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
5. Mai 2026
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
29. April 2026
Zuletzt verifiziert
1. April 2026
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- IRB0150559
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
UNENTSCHIEDEN
Beschreibung des IPD-Plans
As this study involves community-based work with a marginalized population, we want to ensure that researchers accurately represent the population in future research.
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Nein
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Nein
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .
Klinische Studien zur Mindfulness and Identity-Based Micropractice
-
University of California, San FranciscoAbgeschlossenDepression | Angst | TinnitusVereinigte Staaten
-
University of CalgaryRekrutierungBrustkrebs | Darmkrebs | Chemotherapie-EffektKanada
-
University of MiamiUnited States Department of DefenseBeendet
-
University Hospital, GenevaAbgeschlossenGynäkologischer KrebsSchweiz
-
Vanderbilt University Medical CenterAbgeschlossenDepression | Betonen | Ausbrennen | Angst | SelbstmitgefühlVereinigte Staaten
-
Gazi UniversityAbgeschlossenFibromyalgie-SyndromTürkei (türkiye)
-
University of California, San FranciscoNational Center for Complementary and Integrative Health (NCCIH)Aktiv, nicht rekrutierend
-
Amasya UniversityAbgeschlossenAngst | Schwangerschaft bezogenTruthahn
-
Amasya UniversityAbgeschlossenBetonen | Schwangerschaft, hohes RisikoTruthahn
-
Universidad Miguel Hernandez de ElcheBeendetNeurodegenerative Krankheiten | Demenz | Alzheimer ErkrankungSpanien